Related Experiment Video
Updated: Jun 24, 2026

11:29
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
Laparoscopy versus laparotomy for benign ovarian tumour
Lídia R F Medeiros1, Daniela D Rosa, Mary C Bozzetti
1Social Medicine/Epidemiology, Federal University of Rio Grande do Sul, Jose de Alencar 1244, 1009 Menino Deus, Porto Alegre, Rio Grande do Sul, Brazil, 90880-480. lidia.rosi@terra.com.br
The Cochrane Database of Systematic Reviews
|April 17, 2009
Summary
Laparoscopic surgery for benign ovarian tumors offers significant benefits over laparotomy, including fewer complications, less pain, and shorter hospital stays. These advantages contribute to reduced overall costs and improved patient recovery.
Area of Science:
- Gynecologic Oncology
- Minimally Invasive Surgery
- Surgical Outcomes
Background:
- Laparoscopy and minilaparotomy are increasingly common for benign ovarian tumor removal.
- Laparotomy remains the standard for suspected malignant tumors.
- Preoperative assessment aids in surgical approach selection.
Purpose of the Study:
- To compare the benefits, harms, and costs of laparoscopy or minilaparotomy versus laparotomy for benign ovarian tumors.
Main Methods:
- Systematic review of randomized controlled trials (RCTs).
- Searched electronic databases, trial registers, and reference lists.
- Eight reviewers independently assessed study eligibility, quality, and extracted data.
Main Results:
- Laparoscopic surgery showed fewer adverse events (OR 0.3) and less postoperative pain (WMD -2.4) compared to laparotomy.
- Patients undergoing laparoscopy had shorter hospital stays (WMD -2.88 days) and were more likely to be pain-free (OR 7.42).
- Laparoscopy was associated with reduced costs (WMD -USD 1045) and fewer adverse events compared to minilaparotomy in three RCTs.
Conclusions:
- Laparoscopy for benign ovarian tumors reduces fever, infection, complications, pain, and hospital stay, with lower costs.
- Findings should be interpreted cautiously due to a small number of studies (769 women) and incomplete outcome reporting.
